See How Investors Reacted to Cubist Pharmaceuticals Earnings and 3 More Healthcare Stocks

Quest Diagnostics Inc. (NYSE:DGX) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Net income decreased -70.54% to $55.8 million (34 cents per diluted share) in the quarter versus a net gain of $189.44 million in the year-earlier quarter. Revenue decreased 5.82% to $1.77 billion from the year-earlier quarter.

Quest Diagnostics Inc. reported adjusted net income of $1.01 cents per share. By that measure, the company missed the mean analyst estimate of $1.02. It missed the average revenue estimate of $1.8 billion.